Dear colleagues and scientists:
I am asking for your help and insights to develop and explore the feasibility of using an immortalized kidney cell line, for example, HEK293T, for the induction of acute kidney injury. Is the use of drugs known to induce kidney injury remains the best option, or should we use other inducers? And does HEK293T expresses the needed biomarkers of injury such as TNF-alpha, interleukins, KIM-1, and others? Thank you for your help.